PRJNA734957
Gene expression profiles of A375, DLD1, Cal51, Suit2, MDA-MB-231 in response to CDK11 inhibition
We performed RNA-seq for cancer cell lines in response to CDK11 inhibition by selective inhibitor OTS964 (A375, DLD1, Cal51, Suit2 and MDA-MB-231), or by CRISPR-Cas9 mediated CDK11 knock-out (Suit2 and MDA-MB-231).